Keyphrases
Triple-negative Breast Cancer
100%
Risk Reduction
100%
Axillary Lymph Node Status
100%
Delayed Diagnosis
87%
Human Epidermal Growth Factor Receptor 2 (HER2)
62%
Hormone Receptor
37%
Hormone Receptor-negative
25%
Epidermal Growth Factor Receptor
25%
Primary Breast Cancer
25%
Hormone Receptor-positive
25%
Odds Ratio
25%
Human Epidermal Growth Factor Receptor 2-negative
25%
Breast Cancer Patients
25%
Univariate Regression Analysis
12%
Clinical Variables
12%
Women's Status
12%
Axillary Lymph Node Metastasis
12%
Breast Cancer
12%
Regression Analysis
12%
Poor Prognosis
12%
Risk Factors
12%
Cooperative Group
12%
2 Receptor
12%
Tumor Subtype
12%
Working Diagnosis
12%
Tumor
12%
Adjusted Odds Ratio
12%
Medicine and Dentistry
Axillary Lymph Node
100%
Lymph Flow
100%
Triple Negative Breast Cancer
100%
Gamma Urogastrone
77%
Epidermal Growth Factor Receptor 2
77%
Hormone Receptor
77%
Odds Ratio
33%
Breast Cancer
33%
Neoplasm
22%
Lymph Node Metastasis
11%
Nursing and Health Professions
Epidermal Growth Factor Receptor 2
100%
Hormone Receptor
100%
Gamma Urogastrone
100%
Breast Cancer
42%
Odds Ratio
42%
Neoplasm
28%
Lymph Node Metastasis
14%
Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology